Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR2 | P41597 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | MLNR | O43193 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24317161 | 1.00 | CCR2 (0.32) | CCR2SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL13930842 | 0.93 | KDM4E (0.35) | CYP2D6CYP1A2KDM4ENPC1HPGD | |
| Sulfuric Acid SCHEMBL28199639 | 0.89 | CCR2 (0.33) | CCR2FDPS | |
| SCHEMBL23845837 | 0.88 | CCR2 (0.33) | CCR2 | |
| SCHEMBL14474642 | 0.86 | — | — | |
| SCHEMBL26653572 | 0.85 | CYP1A2 (0.34) | CCR2SLC6A2SLC6A4SLC6A3CYP1A2 | |
| SCHEMBL28199029 | 0.83 | CCR2 (0.31) | CCR2 | |
| SCHEMBL21191753 | 0.83 | CCR2 (0.35) | CCR2SLC6A2SLC6A4SLC6A3CYP1A2 | |
| SCHEMBL17307730 | 0.83 | CCR2 (0.32) | CCR2SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL22570154 | 0.83 | CCR2 (0.32) | CCR2SLC6A2SLC6A4SLC6A3CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110510635-A | A kind of Cu-SSZ-39 molecular sieve and its preparation method and application | RES CT FOR ECO ENVIRONMENTAL SCIENCES CAS | 2019-11-29 | — | — | CN | claimed |
| CN-110467200-A | A kind of Cu-SSZ-39 molecular sieve and its preparation method and application | RES CT FOR ECO ENVIRONMENTAL SCIENCES CAS | 2019-11-19 | — | — | CN | claimed |
| CN-106467306-B | The method of one-step synthesis method SSZ-39 molecular sieves | 山东齐鲁华信高科有限公司 | 2018-09-07 | — | — | CN | claimed |
| CN-106467306-A | The method of one-step synthesis method SSZ 39 molecular sieve | 山东齐鲁华信高科有限公司 | 2017-03-01 | — | — | CN | claimed |
| CN-110510635-A | A kind of Cu-SSZ-39 molecular sieve and its preparation method and application | RES CT FOR ECO ENVIRONMENTAL SCIENCES CAS | 2019-11-29 | — | — | CN | disclosed |
| CN-110467200-A | A kind of Cu-SSZ-39 molecular sieve and its preparation method and application | RES CT FOR ECO ENVIRONMENTAL SCIENCES CAS | 2019-11-19 | — | — | CN | disclosed |
| CN-110392607-A | Transition metal-supported zeolite, method for producing same, catalyst for nitrogen oxide purification, and method for using same | 三菱化学株式会社 | 2019-10-29 | — | — | CN | disclosed |
| CN-107074569-B | AEI-type zeolites, methods of making, and uses thereof | 三菱化学株式会社 | 2019-09-13 | — | — | CN | disclosed |
| CN-106467306-B | The method of one-step synthesis method SSZ-39 molecular sieves | 山东齐鲁华信高科有限公司 | 2018-09-07 | — | — | CN | disclosed |
| WO-2018039211-A1 | COMBINATION THERAPY FOR THE TREATMENT OF PANCREATIC CANCER | GENENTECH, INC. (US) | 2018-03-01 | — | — | WO | disclosed |
| CN-107427821-A | Bimetallic Zeolite Catalyst | 庄信万丰股份有限公司 | 2017-12-01 | — | — | CN | disclosed |
| CN-107074569-A | AEI-type zeolites, methods of making, and uses thereof | 三菱化学株式会社 | 2017-08-18 | — | — | CN | disclosed |
| CN-106467306-A | The method of one-step synthesis method SSZ 39 molecular sieve | 山东齐鲁华信高科有限公司 | 2017-03-01 | — | — | CN | disclosed |
| CN-104801338-A | Synthesis of AEI zeolite | JOHNSON MATTHEY PLC | 2015-07-29 | — | — | CN | disclosed |
| US-20090054472-A1 | Pyrazolopyrimidine Derivatives or Pharmaceutically Acceptable Salts Thereof | TEIJIN PHARMA LIMITED (JP) | 2009-02-26 | — | — | US | disclosed |
| US-20090054472-A1 | Pyrazolopyrimidine Derivatives or Pharmaceutically Acceptable Salts Thereof | TEIJIN PHARMA LIMITED (JP) | 2009-02-26 | — | — | US | disclosed |
| CN-1241986-A | A process for preparing zeolites using substituted-piperidinium cations | CHEVRON USA INC (US) | 2000-01-19 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054472-A1 | Pyrazolopyrimidine Derivatives or Pharmaceutically Acceptable Salts Thereof | MAPKAPK2, MAPKAPK5, MAPKAPK3 | CCR2 1326/4885SLC6A2 3775/4885SLC6A4 3814/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.